Tema Oncology ETF Holdings
CANC was created on 2023-08-15 by Tema. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 162.98m in AUM and 58 holdings. CANC is actively managed, investing in stocks of companies focused on cancer treatment and management from issuers all around the world. The fund uses a bottom-up approach to select pioneering companies at perceived attractive valuations.
Last Updated: 5 days, 14 hours ago
Last reported holdings - Tema Oncology ETF
| Ticker | Name | Est. Value |
|---|---|---|
|
RVMD
|
Revolution Medicines Inc Ordinary Shares | $8.5 million |
|
AZN.L
|
AstraZeneca PLC | $7.7 million |
|
NOVN.SW
|
Novartis AG Registered Shares | $7.4 million |
|
LLY
|
Eli Lilly and Co | $7.3 million |
|
RHHBY
|
Roche Holding AG ADR | $7.1 million |
|
COGT
|
Cogent Biosciences Inc | $6.4 million |
|
BMY
|
Bristol-Myers Squibb Co | $6.2 million |
|
IMNM
|
Immunome Inc Ordinary Shares | $6.2 million |
|
BBIO
|
BridgeBio Pharma Inc | $6.0 million |
|
MRK
|
Merck & Co Inc | $6.0 million |
|
NUVL
|
Nuvalent Inc Class A | $5.6 million |
|
JNJ
|
Johnson & Johnson | $5.2 million |
|
CELC
|
Celcuity Inc | $5.2 million |
|
GMAB
|
Genmab AS ADR | $5.0 million |
|
ABBV
|
AbbVie Inc | $4.4 million |
|
EXEL
|
Exelixis Inc | $4.2 million |
|
CGON
|
CG Oncology Inc | $4.2 million |
|
AMGN
|
Amgen Inc | $3.9 million |
|
ERAS
|
Erasca Inc | $3.8 million |
|
ZLAB
|
Zai Lab Ltd ADR Repr 1 Shs | $3.7 million |
|
FXFXX
|
First American Treasury Obligs X | $3.7 million |
|
IDYA
|
IDEAYA Biosciences Inc | $3.6 million |
|
ONC
|
BeOne Medicines Ltd ADR | $3.5 million |
|
LEGN
|
Legend Biotech Corp ADR | $3.4 million |
|
ZYME
|
Zymeworks Inc Registered Shs | $2.7 million |
|
SMMT
|
Summit Therapeutics Inc Ordinary Shares | $2.3 million |
|
HALO
|
Halozyme Therapeutics Inc | $2.1 million |
|
GILD
|
Gilead Sciences Inc | $2.0 million |
|
4519.T
|
Chugai Pharmaceutical Co Ltd | $1.9 million |
|
RCUS
|
Arcus Biosciences Inc | $1.8 million |
|
ELVN
|
Enliven Therapeutics Inc | $1.8 million |
|
NUVB
|
Nuvation Bio Inc Ordinary Shares - Class A | $1.8 million |
|
ANAB
|
AnaptysBio Inc | $1.8 million |
|
IMTX
|
Immatics NV Ordinary Shares | $1.7 million |
|
RLAY
|
Relay Therapeutics Inc Ordinary Shares | $1.7 million |
|
REGN
|
Regeneron Pharmaceuticals Inc | $1.7 million |
|
SNDX
|
Syndax Pharmaceuticals Inc | $1.6 million |
|
CRVS
|
Corvus Pharmaceuticals Inc | $1.6 million |
|
URGN
|
UroGen Pharma Ltd | $1.4 million |
|
GH
|
Guardant Health Inc | $1.3 million |
|
OLMA
|
Olema Pharmaceuticals inc Ordinary Shares | $1.2 million |
|
CTMX
|
CytomX Therapeutics Inc | $1.0 million |
|
HCM
|
HUTCHMED (China) Ltd ADR | $1.0 million |
|
NTRA
|
Natera Inc | $1.0 million |
|
ARVN
|
Arvinas Inc | $946973 |
|
IMCR
|
Immunocore Holdings PLC ADR | $929032 |
|
CGEM
|
Cullinan Therapeutics Inc | $870149 |
|
REPL
|
Replimune Group Inc | $813395 |
|
CMPX
|
Compass Therapeutics Inc Ordinary Shares | $750839 |
|
JANX
|
Janux Therapeutics Inc Ordinary Shares | $742752 |
|
BBOT
|
BridgeBio Oncology Therapeutics Inc | $742013 |
|
IOVA
|
Iovance Biotherapeutics Inc | $635197 |
|
ALLO
|
Allogene Therapeutics Inc | $560824 |
|
ANL
|
Adlai Nortye Ltd ADR | $521669 |
|
ORIC
|
ORIC Pharmaceuticals Inc | $430575 |
|
SLS
|
SELLAS Life Sciences Group Inc | $378929 |
|
AAPG
|
Ascentage Pharma Group International ADR | $286626 |
|
None
|
JAPANESE YEN | $14646 |
|
None
|
US DOLLARS | $7855 |
Recent Changes - Tema Oncology ETF
| Date | Ticker | Name | Change (Shares) |
|---|